Download PDF
Journal of Pediatric Neurology 2024; 22(01): 060-063
DOI: 10.1055/s-0042-1760196
Case Report

Limb Hypertrophy—An Uncommon Presentation Yet a Common Link among Neurocutaneous Syndromes: A Series of Three Cases

Akriti Agrawal 
1   Department of Dermatology, Venereology and Leprology, All India Institute of Medical Sciences (AIIMS) Jodhpur, Rajasthan, India
,
Anil Budania
1   Department of Dermatology, Venereology and Leprology, All India Institute of Medical Sciences (AIIMS) Jodhpur, Rajasthan, India
,
Lokesh Saini
2   Department of Pediatrics, All India Institute of Medical Sciences (AIIMS) Jodhpur, Rajasthan, India
,
Sarbesh Tiwari
3   Department of Radiology, All India Institute of Medical Sciences (AIIMS) Jodhpur, Rajasthan, India
,
Deepak Vedant
4   Department of Pathology, All India Institute of Medical Sciences (AIIMS) Jodhpur, Rajasthan, India
,
Benetta Benny
1   Department of Dermatology, Venereology and Leprology, All India Institute of Medical Sciences (AIIMS) Jodhpur, Rajasthan, India
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Limb hypertrophy is an unusual presentation associated with neurocutaneous syndromes. The mechanism behind this presentation may vary from case to case. Here, we describe a case series of three different syndromes linked by a common clinical finding of limb hypertrophy.

Keywords

neurocutaneous syndromes - limb hypertrophy - mTOR

Written Informed Consent

Written informed consent has been obtained from the patients for publication purposes.




Publication History

Received: 26 July 2022

Accepted: 20 November 2022

Article published online:
30 December 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Keppler-Noreuil KM, Rios JJ, Parker VE. et al. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A 2015; 167A (02) 287-295
    CrossrefPubMedGoogle Scholar
  • 2 Jett K, Friedman JM. Clinical and genetic aspects of neurofibromatosis 1. Genet Med 2010; 12 (01) 1-11
    CrossrefPubMedGoogle Scholar
  • 3 Stevenson DA, Viskochil DH, Rope AF, Carey JC. Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype. Clin Genet 2006; 69 (03) 246-253
    CrossrefPubMedGoogle Scholar
  • 4 Nyström AM, Ekvall S, Allanson J. et al. Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1. Clin Genet 2009; 76 (06) 524-534
    CrossrefPubMedGoogle Scholar
  • 5 Ponti G, Pellacani G, Martorana D. et al. Giant elephantiasis neuromatosa in the setting of neurofibromatosis type 1: a case report. Oncol Lett 2016; 11 (06) 3709-3714
    CrossrefPubMedGoogle Scholar
  • 6 Jenkins D, McCuaig C, Drolet BA. et al. Tuberous sclerosis complex associated with vascular anomalies or overgrowth. Pediatr Dermatol 2016; 33 (05) 536-542
    CrossrefPubMedGoogle Scholar
  • 7 Reddy BSN, Sheriff MO, Garg BR, Ratnakar C. A rare association of localized gigantism with tuberous sclerosis. J Dermatol 1992; 19 (10) 622-625
    CrossrefPubMedGoogle Scholar
  • 8 Hirsch RJ, Silverberg NB, Laude T, Weinberg JM. Tuberous sclerosis associated with congenital lymphedema. Pediatr Dermatol 1999; 16 (05) 407-408
    CrossrefPubMedGoogle Scholar
  • 9 Voudris KA, Skardoutsou A, Vagiakou EA. Tuberous sclerosis and congenital lymphedema. Pediatr Dermatol 2003; 20 (04) 371-373
    CrossrefPubMedGoogle Scholar
  • 10 Lucas M, Andrade Y. Congenital lymphedema with tuberous sclerosis and clinical Hirschsprung disease. Pediatr Dermatol 2011; 28 (02) 194-195
    CrossrefPubMedGoogle Scholar
  • 11 Purkait R, Samanta T, Sinhamahapatra T, Chatterjee M. Overlap of sturge-weber syndrome and klippel-trenaunay syndrome. Indian J Dermatol 2011; 56 (06) 755-757
    CrossrefPubMedGoogle Scholar
  • 12 Rao AG, Reddy VS, Parimala MD. et al. Sturge-Weber syndrome coexisting with multiple vertebral vascular malformations and hemivertebra with scoliosis and upper limb and ear hypertrophy. Indian J Dermatol Venereol Leprol 2020; 86 (02) 187-190
    CrossrefPubMedGoogle Scholar
  • 13 Giacaman A, Salinas Sanz JA, Navarro Noguera S, Lastra Rodríguez J, Montis Palos MC, Martín-Santiago A. Facial hemihypertrophy in a girl with sturge-weber syndrome: treatment with oral sirolimus. Pediatr Dermatol 2021; 38 (02) 469-471
    CrossrefPubMedGoogle Scholar
  • 14 Vahidnezhad H, Youssefian L, Uitto J. Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS). Exp Dermatol 2016; 25 (01) 17-19
    CrossrefPubMedGoogle Scholar
  • 15 Gross AM, Wolters PL, Dombi E. et al. Selumetinib in children with inoperable plexiform neurofibromas. N Engl J Med 2020; 382 (15) 1430-1442
    CrossrefPubMedGoogle Scholar
  • 16 Blegen K, Ortiz-Romero SE, Juarez O, Voeller J. Clinical impact of selumetinib on pediatric elephantiasis neuromatosa. Pediatr Dermatol 2022; 39 (05) 764-766
    CrossrefPubMedGoogle Scholar
  • 17 Franz DN, Krueger DA. mTOR inhibitor therapy as a disease modifying therapy for tuberous sclerosis complex. Am J Med Genet C Semin Med Genet 2018; 178 (03) 365-373
    CrossrefPubMedGoogle Scholar